Medtronic (MDT) Depreciation & Amortization (CF) (2014 - 2026)

Medtronic has reported Depreciation & Amortization (CF) for 13 years, with the latest figure at $716.0 million in Q2 2026.

• Quarterly Depreciation & Amortization (CF) fell 14.76% year-over-year to $716.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3.0 billion (up 3.39% YoY) and the FY2026 annual result came in at $3.0 billion, up 3.39% from the prior year.
• Depreciation & Amortization (CF) declined to $716.0 million in Q2 2026 per MDT's latest filing, from $749.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $840.0 million in Q2 2025 and troughed at $649.0 million in Q1 2024.
• A 5-year average of $695.7 million and a median of $677.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) rose 28.44% in 2025, then retreated 14.76% in 2026.
• Over 5 years, Depreciation & Amortization (CF) stood at $671.0 million in 2022, then grew by 0.15% to $672.0 million in 2023, then gained by 0.45% to $675.0 million in 2024, then grew by 10.37% to $745.0 million in 2025, then dropped by 3.89% to $716.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $716.0 million, $749.0 million, and $745.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.